Tudor Investment Corp’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,703
Closed -$311K 3739
2025
Q3
$245K Sell
1,703
-132,307
-99% -$16.2M ﹤0.01% 3101
2025
Q2
$13.5M Buy
+134,010
New +$10.2M 0.03% 511
2024
Q4
Sell
-11,886
Closed -$856K 3242
2024
Q3
$868K Buy
+11,886
New +$877K ﹤0.01% 1709
2024
Q1
Sell
-23,044
Closed -$714K 2472
2023
Q4
$714K Sell
23,044
-2,373
-9% -$61.5K 0.01% 1610
2023
Q3
$642K Sell
25,417
-13,661
-35% -$312K 0.01% 1549
2023
Q2
$825K Sell
39,078
-30,180
-44% -$573K 0.01% 1415
2023
Q1
$1.18M Sell
69,258
-3,723
-5% -$72.3K 0.02% 1093
2022
Q4
$1.46M Buy
72,981
+10,790
+17% +$209K 0.03% 835
2022
Q3
$1.34M Buy
62,191
+157
+0.3% +$3.76K 0.03% 741
2022
Q2
$1.22M Buy
62,034
+16,664
+37% +$349K 0.03% 765
2022
Q1
$1.07M Buy
45,370
+6,999
+18% +$163K 0.03% 885
2021
Q4
$1.04M Buy
+38,371
New +$1.1M 0.02% 970
2020
Q1
Sell
-19,419
Closed -$464K 1182
2019
Q4
$464K Buy
19,419
+2,026
+12% +$41.2K 0.02% 744
2019
Q3
$307K Sell
17,393
-33,068
-66% -$639K 0.01% 847
2019
Q2
$1.29M Buy
50,461
+31,432
+165% +$876K 0.04% 451
2019
Q1
$553K Buy
+19,029
New +$493K 0.02% 672
2018
Q2
Sell
-15,066
Closed -$339K 1133
2018
Q1
$339K Buy
15,066
+6,044
+67% +$159K 0.01% 692
2017
Q4
$281K Sell
9,022
-26,647
-75% -$787K 0.01% 835
2017
Q3
$1.11M Buy
35,669
+14,047
+65% +$268K 0.03% 353
2017
Q2
$371K Buy
21,622
+5,955
+38% +$102K 0.01% 684
2017
Q1
$274K Sell
15,667
-7,220
-32% -$111K 0.01% 1057
2016
Q4
$303K Sell
22,887
-149
-0.6% -$2.03K 0.01% 1021
2016
Q3
$334K Sell
23,036
-5,127
-18% -$64.2K 0.01% 952
2016
Q2
$278K Buy
28,163
+6,610
+31% +$77.1K 0.01% 1216
2016
Q1
$273K Buy
+21,553
New +$283K 0.01% 1342
2015
Q4
Sell
-18,238
Closed -$339K 1742
2015
Q3
$339K Buy
+18,238
New +$455K 0.01% 1015
2015
Q2
Sell
-27,175
Closed -$565K 1576
2015
Q1
$565K Buy
+27,175
New +$479K 0.02% 668

Other funds holding INSM

Tudor Investment Corp's INSM Position: Q4 2025 in Review

Tudor Investment Corp sold out of Insmed (INSM) in Q4 2025, closing a stake of 1,703 shares — an estimated $311K sold.

Tudor Investment Corp first reported a position in INSM in Q1 2015 and held it in 27 quarters. The position peaked at $13.5M in Q2 2025. 677 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

  • Tudor Investment Corp reported no remaining Insmed position as of Q4 2025 after selling out during the quarter.
  • Tudor Investment Corp sold 1,703 Insmed shares in Q4 2025, an estimated $311K.
  • Tudor Investment Corp first reported a position in Insmed in Q1 2015 and held it in 27 quarters.
  • Tudor Investment Corp's Insmed position peaked at $13.5M in Q2 2025.
  • 677 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on Tudor Investment Corp's 13F filing for Q4 2025, filed 17 Feb 2026.